Clinical Trials Logo

Filter by:
NCT ID: NCT04771195 Enrolling by invitation - Depression Clinical Trials

Social Factors in the Mental Health of Young Adults: Bridging Psychological and Network Analysis

Start date: August 30, 2021
Phase:
Study type: Observational

The central goal of this project is to produce a novel, precise, and comprehensive account of social factors in young adult mental health - using a novel combination of network nominations, ecological momentary assessment, and neuroimaging methods. To that end, the investigators will collect data from two successive classes of college undergraduates (i.e., classes of 2023 and 2024) over the course of their collegiate tenure.

NCT ID: NCT04824612 Enrolling by invitation - Keloid Clinical Trials

Photobiomodulation and the Intralesional Administration of Corticoid in the Keloid Surgery.

Start date: August 30, 2021
Phase: N/A
Study type: Interventional

A randomized, controlled, double-blind, clinical trial will be conducted to study the evaluate the effect of blue light combined with corticoid treatment in the preoperative and postoperative period of keloid removal surgery.

NCT ID: NCT04957550 Enrolling by invitation - Psoriatic Arthritis Clinical Trials

To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis

Start date: August 30, 2021
Phase: Phase 3
Study type: Interventional

This study is a phase 3 study,to evaluate the efficacy and safety of different doses of JAK1 inhibitor SHR0302 in subjects with active psoriatic arthritis.

NCT ID: NCT04974541 Enrolling by invitation - Clinical trials for Ischemic Heart Disease

Improving Wellbeing in Ischemic Heart Disease

Start date: August 30, 2021
Phase: N/A
Study type: Interventional

The purpose of this research is to see if Heart Health Yoga (HHY) Program when added on to standard cardiac rehabilitation (CR) will improve overall wellbeing and quality of life for patients experiencing ischemic heart disease, heart problems caused by narrowed heart arteries.

NCT ID: NCT05500521 Enrolling by invitation - Vestibular Disorder Clinical Trials

Association Between Severe-to-profound Hearing Loss and the Balance Function of the Inner Ear

Start date: August 30, 2022
Phase:
Study type: Observational

Severe-to-profound hearing loss can have a major impact on patients´ lives leading to social isolation and decreased quality of life. Most commonly the hearing loss is caused by damage to the inner ear or cochlear nerve. Since the vestibular system which is central for our balance is located in the inner ear it can be suspected that patients with severe-to-profound hearing loss also might have an impaired vestibular function. This impairment may lead to a feeling of dizziness or vertigo. This study aims to investigate if patients with severe-to-profound hearing loss also have impaired vestibular function. The vestibular function will be measured with caloric irrigation, video head impulse test and vestibular evoked myogenic potential.

NCT ID: NCT05504902 Enrolling by invitation - Parkinson Disease Clinical Trials

Vibrotactile Coordinated Reset for the Treatment of Advanced Parkinson's Disease

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on advanced stage Parkinson's symptoms. VCR will be administered with a device called the Stanford CR Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as levodopa and or deep brain stimulation. Patients will be followed for two years.

NCT ID: NCT05852262 Enrolling by invitation - Cellulitis Clinical Trials

High-dose Cephalexin for Cellulitis (HI-DOCC)

HI-DOCC
Start date: August 30, 2023
Phase: Phase 4
Study type: Interventional

Cellulitis is a common condition diagnosed and managed in the ED that carries significant burden on healthcare systems globally. Cellulitis is the 8th most common reason patients present to an ED in Canada. Among middle-aged patients (45-64 years) it is the 5th most common reason to visit an ED. This disease is responsible for significant healthcare system burden due to high hospitalization rates and subsequent costs. The Investigators conducted a health records review at two large urban EDs in Ottawa, and found that 29.6% of patients with cellulitis are admitted to hospital. In a separate study, The investigators found that the mean cost of care to hospitalize cellulitis patients for IV antibiotics was $10,145 CDN.

NCT ID: NCT05962398 Enrolling by invitation - Hemophilia B Clinical Trials

Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)

Start date: August 30, 2023
Phase:
Study type: Observational

The primary purpose of this study is to assess the long-term safety in male adults with hemophilia B who were treated with CSL222 in studies CSL222_2001 (NCT03489291) or CSL222_3001 (NCT03569891).

NCT ID: NCT05980234 Enrolling by invitation - Osteoarthritis Clinical Trials

MDR - Longevity IT Oblique and Offset Liners

Start date: August 30, 2023
Phase:
Study type: Observational

The objective of this retrospective enrollment/prospective follow-up consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Longevity IT Oblique and Offset liners when used for primary or revision total hip arthroplasty (implants and instrumentation) at a minimum of 10-year follow-up.

NCT ID: NCT05998005 Enrolling by invitation - Clinical trials for Substance-Related Disorders

First Face Training Evaluation in Tribal Communities

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate a culturally grounded training curriculum, First Face for Mental Health, in Tribal communities, using a waitlist controlled randomized trial design. This curriculum will train Tribal community members in how to respond to youth and adults experiencing mental health crises and serve as a bridge between these individuals and the help they need. The main questions the study aims to answer are: - Does the training increase mental health knowledge, capacity and ability to respond to mental health situations, perceived competence to respond, and actual responsive actions among trainees? - Does the training decrease mental health stigmatizing attitudes and increase cultural identity among trainees? Participants will complete surveys before and after completing the First Face training, across five time points over the course of two years. Half of the participants will be randomized to receive the training initially, and half will receive it six months later. Researchers will compare the two groups to examine whether the trainees demonstrate changes in the outcomes of interest compared to the waitlist control group during the first six months, and whether both groups demonstrate sustained changes after the first six months (i.e., once both groups have received training).